Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028?

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028? It is currently trading at a 41% probability on Kalshi. Scheduled resolution: January 1, 2032.

Last updated September 1, 2026 at 3:26 AM ET

Current Market Probability

Probability Price Platform Status Resolution date Chart
41% 0.41 Kalshi Open January 01, 2032 View chart

Market Information

Historical Market Probability

7 days ago 30 days ago Current
41% 31% 41%

Related Prediction Markets

Popular Prediction Markets